Home » Health » COVID-19 Vaccine: Who Should Get It & Why Now?

COVID-19 Vaccine: Who Should Get It & Why Now?

by Dr. Michael Lee – Health Editor

COVID-19​ Cases Rising: Health Officials ⁤Urge Vaccination, Debate Optimal Timing

PARIS – As COVID-19​ cases begin to climb,⁣ French health authorities are launching a⁤ vaccination campaign utilizing an updated Pfizer ​vaccine tailored to the Omicron LP.8.1 variant, ‍but questions remain about‍ the timing and public uptake. The‍ campaign, slated to officially begin ⁢October 14th, prioritizes those most vulnerable⁢ to severe illness – individuals who have had⁢ a ⁣recent COVID-19 infection⁤ or vaccine dose within the past six ​months, immunocompromised ⁣individuals, and those aged 80 or older, who are eligible for​ a booster after just three ⁣months.

Despite recommendations, vaccination rates remain low, with‍ only 20% of those‍ over 65 and 17% of all ⁣eligible individuals receiving a dose last year. Health ⁢officials emphasize the ‍vaccine’s‌ effectiveness in preventing ⁢serious illness and hospitalization, particularly during⁢ peak periods, ⁤but acknowledge the ‍relatively short duration of immunity conferred by ‍mRNA vaccines. The goal is to encourage⁤ annual vaccination, similar to the flu shot, focusing on​ protecting the ⁤most fragile populations.

The Cumirnaty vaccine, authorized by the European Medicines Agency in July, is considered a close enough match to currently circulating strains to provide ⁤good protection⁣ against severe outcomes. However, ⁢experts like Infectiologist Odile⁢ Launay,​ speaking to Le Parisien, note that “The duration of the immune response with our⁣ messenger⁢ RNA vaccines is relatively short,” meaning protection ⁤diminishes over time.

A point of contention is the ‌October 14th launch date. Several specialists argue that waiting until mid-October could diminish the campaign’s impact, as the⁢ peak of infections may have already passed. Virologist Bruno Lina, in comments to Le Parisian, ⁤warned, “Starting a vaccination campaign when the peak ⁣has passed, it’s terrible!” He points⁢ to 2023,‌ when France advanced the launch​ to October 2nd,⁢ and England even​ earlier to September 11th, ‌in ​response to‍ an⁢ early ⁣wave. While doses are⁣ expected to be delivered to pharmacies starting October 2nd, the Ministry of Health has stated no changes ⁢to the launch date are currently planned.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.